TH162687A - Bihetero Aryl Compounds And their use - Google Patents
Bihetero Aryl Compounds And their useInfo
- Publication number
- TH162687A TH162687A TH1501006596A TH1501006596A TH162687A TH 162687 A TH162687 A TH 162687A TH 1501006596 A TH1501006596 A TH 1501006596A TH 1501006596 A TH1501006596 A TH 1501006596A TH 162687 A TH162687 A TH 162687A
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- formulas
- diseases
- variables
- salts
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title 1
- 206010053643 Neurodegenerative disease Diseases 0.000 claims abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000011780 sodium chloride Substances 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000001225 therapeutic Effects 0.000 claims 1
Abstract
แก้ไข 21/01/2559 การประดิษฐ์ครั้งนี้จะจัดหาสารประกอบตามสูตร I-I และรูปแบบ และเกลือของ พวกมันสำหรับการบำบัดโรค (ได้แก่, โรคเกี่ยวกับการเสื่อมของประสาท) ตัวแปร R1, R2, R3, X1, X2, A และ Cy ในสูตร I-I ทั้งหมดจะมีความหมายดังที่นิยามไว้ในที่นี้ (สูตรเคมี) ---------------------------------------------------------------------------------- การประดิษฐ์ครั้งนี้จะจัดหาสารประกอบตามสูตร I-I และรูปแบบ และเกลือของพวก มันสำหรับการบำบัดโรค (ได้แก่, โรคเกี่ยวกับการเสื่อมของประสาท) ตัวแปร R1, R2, R3, X1, X2, A และ Cy ในสูตร I-I ทั้งหมดจะมีความหมายดังที่นิยามไว้ในที่นี้ (สูตรเคมี) สูตร I-I สิทธิบัตรยา Revised 01/21/2016 This invention will supply compounds based on Formula II and their forms and salts for the treatment of diseases (viz., Neurodegenerative diseases) variables R1, R2, R3, X1, X2, All A and Cy in formula II have their meanings as defined here (chemical formula) ----------------------------- -------------------------------------------------- --- This invention supplies compounds according to Formula II and their forms and salts. It is for the treatment of diseases (ie, neurodegenerative diseases) the variables R1, R2, R3, X1, X2, A and Cy in all formulas are defined here (chemical formulas) Formula II. Drug patent
Claims (1)
Publications (3)
| Publication Number | Publication Date |
|---|---|
| TH162687A true TH162687A (en) | 2017-05-25 |
| TH162687B TH162687B (en) | 2017-05-25 |
| TH1501006596A TH1501006596A (en) | 2017-05-25 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791420A1 (en) | TRIAZOLOPYRIMIDIN COMPOUNDS AND THEIR APPLICATIONS | |
| EA201790271A1 (en) | GLYCOSIDASE INHIBITORS | |
| DOP2016000271A (en) | FUSIONED BICYCLIC HETEROARILO OR ARILO COMPOUNDS | |
| CR20150589A (en) | BIHETEROARILO COMPOUNDS AND USES OF THE SAME | |
| CY1117580T1 (en) | NEW HYDROCYCLIC PRODUCTS AND THEIR USE IN NEUROLOGICAL DISORDER TREATMENT | |
| UY35821A (en) | HETEROCYCLIC COMPOUND | |
| CY1120354T1 (en) | DYCYLGYLGEROL 2 ACYLOTHER TRANSFER DISPOSALS FOR USE IN TREATMENT OF METABOLIC AND CON associated Disorders | |
| CU20160188A7 (en) | INDAZOLE COMPOUNDS SUBSTITUTED AS IRAK4 INHIBITORS | |
| MX2016008688A (en) | Therapeutic inhibitory compounds. | |
| CU24389B1 (en) | BICYCLIC HETEROCICLYL COMPOUNDS AS IRAK4 INHIBITORS | |
| UA116648C2 (en) | FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES | |
| PE20151542A1 (en) | TETRAHYDROPYRROTHIAZINE COMPOUNDS | |
| ECSP14013329A (en) | ARYLCARBONIL-4-OXY-PIPERIDINE COMPOUNDS USED FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| DOP2019000193A (en) | NEW HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | |
| EA201691600A1 (en) | DIHYDROPYRIDINOUS INHIBITORS MGAT2 FOR USE IN THE TREATMENT OF METABOLIC DISORDERS | |
| EA201790207A1 (en) | NEW SUBSTITUTED PYRIMIDINE COMPOUNDS | |
| CY1122375T1 (en) | TETRAHYDROFURAN-CONDENSED AMINOHYDROTHIAZINE ANALOGS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
| DOP2016000325A (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| TH162687A (en) | Bihetero Aryl Compounds And their use | |
| TH162687B (en) | Bihetero aeryl And their use | |
| TH1701003495A (en) | Triazolopyrimidine and its use | |
| TH167426A (en) | Hetero-aeryl or bicyclic-bonded aryl compounds and their use That substance as an IRAK4 inhibitor | |
| EA201892188A1 (en) | PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS | |
| TH169293A (en) | BACEI inhibitors | |
| TH1701001398A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller |